Ketorolac
- Generic Name
- Ketorolac
- Brand Names
- Acular, Acuvail, Omidria, Readysharp Anesthetics Plus Ketorolac, Sprix, Toradol, Toronova Suik
- Drug Type
- Small Molecule
- Chemical Formula
- C15H13NO3
- CAS Number
- 74103-06-3
- Unique Ingredient Identifier
- YZI5105V0L
- Background
Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.
...
- Indication
Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and has antipyretic, analgesic and anti-inflammatory properties. It is indicated for short term management of acute pain that requires the calibre of pain management offered by opioids. Clinicians may choose to initiate ketorolac to manage post-operative pain, spinal and soft tissue pain, rheumatoid...
- Associated Conditions
- Acute Migraine, Eye Pain, Inflammation, Macular Edema, Cystoid, Ocular Itching, Pericarditis Acute, Pseudophakic Cystoid Macular Oedema, Severe Acute Pain, Acute, moderate Pain, Chronic aphakic cystoid macular edema, Intraoperative miosis, Postoperative ocular pain
- Associated Therapies
- -
Prophylactic Intravenous Injection of Neostigmine Plus Atropine Versus Ketorolac on Post-dural Puncture Headache in Patients Undergoing Infraumbilical Surgeries
- Conditions
- Interventions
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 330
- Registration Number
- NCT06729047
- Locations
- 🇪🇬
Faculty of medicine, Assiut University, Assiut, Egypt,, Assiut, Egypt
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
- Conditions
- Interventions
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 44
- Registration Number
- NCT06653400
- Locations
- 🇺🇸
Mount Sinai, New York, New York, United States
Ketorolac for Acute Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease
- Conditions
- Interventions
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2024-08-30
- Target Recruit Count
- 102
- Registration Number
- NCT06579703
Ketorolac Effects on Post-operative Pain and Lumbar Fusion
- Conditions
- Interventions
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- University of Maryland St. Joseph Medical Center
- Target Recruit Count
- 140
- Registration Number
- NCT06513208
Pain Control After Lumbar Spine Fusion
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Rothman Institute Orthopaedics
- Target Recruit Count
- 428
- Registration Number
- NCT06484192
- Locations
- 🇺🇸
Rothman Orthopaedic Institute, Philadelphia, Pennsylvania, United States
Controlled Trial to Determine Most Effective Post-Operative Analgesia After Third Molar Extraction
- Conditions
- Interventions
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- United States Naval Medical Center, San Diego
- Target Recruit Count
- 80
- Registration Number
- NCT06484439
- Locations
- 🇺🇸
Naval Medical Center San Diego, San Diego, California, United States
Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department
- Conditions
- Interventions
- First Posted Date
- 2024-05-02
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Western Michigan University School of Medicine
- Target Recruit Count
- 75
- Registration Number
- NCT06395428
- Locations
- 🇺🇸
Bronson Methodist Hospital, Kalamazoo, Michigan, United States
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
- Conditions
- Interventions
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 58
- Registration Number
- NCT06326983
- Locations
- 🇺🇸
Boston Children's Hospital, Waltham, Massachusetts, United States
Treatment of Topical Ketorolac Gel in Acute Gouty Flare
- Conditions
- Interventions
- First Posted Date
- 2024-02-23
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Novilla Pharmaceuticals
- Target Recruit Count
- 30
- Registration Number
- NCT06273813
- Locations
- 🇦🇺
Paratus Clinical,, Blacktown, Australia
🇦🇺Linear Clinical Research Ltd, Nedlands, Australia
Combined Ketorolac Bupivacaine Versus Bupivacaine Alone for TAP Block in Children Undergoing Lower Abdominal Surgeries
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Sohag University
- Target Recruit Count
- 90
- Registration Number
- NCT06267820
- Locations
- 🇪🇬
Fouad Ibrahim Soliman, Sohag, Egypt
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.